insulin potentiation therapy
Also found in: Acronyms, Encyclopedia, Wikipedia.
insulin potentiation therapyFringe oncology
The use of insulin to markedly reduce a cancer patient’s serum glucose levels (e.g., to 40 mg/dl) while co-administering chemotherapy. According to the theory, intracellular hypoglycaemia potentiates the chemotherapy’s effect, increasing tumour killer rates and allowing the toxic ages to be reduced to 10–15% of that needed in absence of insulin. IPT is not a recognised philosophy among mainstream oncologists, as it is ineffective.